Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Jordi Gascón-Bayarri"'
Autor:
Inés del Cerro, Ignacio Martínez-Zalacaín, Andrés Guinea-Izquierdo, Jordi Gascón-Bayarri, Vanesa Viñas-Diez, Mikel Urretavizcaya, Pablo Naval-Baudin, Carlos Aguilera, Ramón Reñé-Ramírez, Isidre Ferrer, José M. Menchón, Virginia Soria, Carles Soriano-Mas
Publikováno v:
NeuroImage: Clinical, Vol 28, Iss , Pp 102482- (2020)
The Locus Coeruleus (LC) is the major source of noradrenergic neurotransmission. Structural alterations in the LC have been observed in neurodegenerative disorders and at-risk individuals, although functional connectivity studies between the LC and o
Externí odkaz:
https://doaj.org/article/753102352dda449886e64ccef0918275
Autor:
Ana Gámez-Valero, Jaume Campdelacreu, Dolores Vilas, Lourdes Ispierto, Jordi Gascón-Bayarri, Ramón Reñé, Ramiro Álvarez, Maria P. Armengol, Francesc E. Borràs, Katrin Beyer
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1272 (2021)
Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia, after Alzheimer’s disease (AD), and presents pathological and clinical overlap with both AD and Parkinson’s disease (PD). Consequently, only one in three D
Externí odkaz:
https://doaj.org/article/1d4fbc85356e43948fce8534a7b578c1
Autor:
Laura Marsal-García, Aintzane Urbizu, Laura Arnaldo, Jaume Campdelacreu, Dolores Vilas, Lourdes Ispierto, Jordi Gascón-Bayarri, Ramón Reñé, Ramiro Álvarez, Katrin Beyer
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 725 (2021)
Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. Therefore, we analyzed the expre
Externí odkaz:
https://doaj.org/article/a73f43b2b6834f16b92a420d1e9c0204
Autor:
Jordi Gascón-Bayarri, Jaume Campdelacreu, Màtil Calopa, Serge Jaumà, Laura Bau, Mònica Povedano, Jordi Montero
Publikováno v:
Case Reports in Neurological Medicine, Vol 2012 (2012)
Forehead tremor has only been reported in two patients with essential tremor, one with rhythmic tremor and the other with dystonic tremor. We report 4 new patients with essential tremor who present a 4–6 Hz frontal tremor registered by electromyogr
Externí odkaz:
https://doaj.org/article/0c44b1b5f8c84a76b56484315a4c82ac
Autor:
Jordi Gascón-Bayarri, Petru Cristian Simon, Roser Llop, Thiago Carnaval, María Dolores Ledesma, Imma Rico, Cristina Sánchez-Castañeda, Jaume Campdelacreu-Fumadó, Nahum Calvo-Malvar, Mònica Cos, Eugenia de Lama, Montserrat Cortés-Romera, Laura Rodríguez-Bel, Celia Pérez-Sousa, María Cerdán Sánchez, Nuria Muelas, María Dolores Sevillano, Pablo Mir, Adolfo López de Munain, Anna Ferrer, Sebastián Videla
[Background] Niemann-Pick disease Type C (NPC) is a genetic, incurable, neurodegenerative disorder. This orphan disease is most frequently caused by mutations in the NPC1 protein, resulting in intralysossomal cholesterol accumulation. NPC1 is found i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a04d0315f0d7d73f664a47faca42569
http://hdl.handle.net/10810/59488
http://hdl.handle.net/10810/59488
Autor:
Jordi Gascón Bayarri, Yasmina Amraoui, Michael Strupp, Larry A Abel, Miriam Kolníková, Eugen Mengel, Stanislavs Bardins, Ali Reza Tavasoli, Tatiana Bremova-Ertl, Anna Ardissone, Ettore Salsano, Andreas Brecht, Věra Malinová, Mark Walterfang, Mahmoud Reza Ashrafi, Stefan A Kolb
Publikováno v:
European Journal of Neurology
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Objective To characterize ocular motor function in patients with Niemann‐Pick disease type C (NPC). Methods In a multicontinental, cross‐sectional study we characterized ocular‐motor function in 72 patients from 12 countries by video‐oculogra
Autor:
Sergio Martínez-Yélamos, Carlos Casasnovas, Jacint Sala-Padró, Sara Castañer, Noemi Vidal, J. Mora, Sònia Jaraba, Júlia Miró, Francisco Morandeira, Misericordia Veciana, Laura Rodriguez-Bel, Albert Saiz, Pablo Arroyo, Mar Carreño, Jordi Gascón-Bayarri, Eva Real, Mercè Falip
Publikováno v:
Seizure. 81:157-165
Objective To follow prospectively a group of patients with seizures or epilepsy and suggestive clinical features of autoimmune aetiology and find out how many are finally diagnosed with acute symptomatic seizures (ASS) secondary to autoimmune encepha
Autor:
Anita Hennig, Jens Claassen, Tatiana Bremova-Ertl, Miriam Kolnikova, Uma Ramaswami, Simon Jones, Jan Raethjen, Kyriakos Martakis, Paul Gissen, Susanne A. Schneider, Anhar Hassan, Tomas Foltan, Reena Sharma, Jordi Gascón-Bayarri, Andreas Hahn
Publikováno v:
Bremova-Ertl, Tatiana; Claassen, Jens; Foltan, Tomas; Gascon-Bayarri, Jordi; Gissen, Paul; Hahn, Andreas; Hassan, Anhar; Hennig, Anita; Jones, Simon A; Kolnikova, Miriam; Martakis, Kyriakos; Raethjen, Jan; Ramaswami, Uma; Sharma, Reena; Schneider, Susanne A (2022). Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C. Journal of neurology, 269(3), pp. 1651-1662. Springer 10.1007/s00415-021-10717-0
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Neurology
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Neurology
Objective To investigate the safety and efficacy of N-acetyl-l-leucine (NALL) on symptoms, functioning, and quality of life in pediatric (≥ 6 years) and adult Niemann–Pick disease type C (NPC) patients. Methods In this multi-national, open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101d4f5ad5e2702e3c802f701f642125
https://boris.unibe.ch/160811/1/Bremova_Ertl__2021__Efficacy_and_safety.pdf
https://boris.unibe.ch/160811/1/Bremova_Ertl__2021__Efficacy_and_safety.pdf
Autor:
Simon Jones, Jens Claassen, Anita Hennig, Nicolina Goldschagg, Jordi Gascón-Bayarri, Susan Perlman, Andreas Hahn, Tatiana Bremova-Ertl, Susanne A. Schneider, Kyriakos Martakis, Reena Sharma, Anhar Hassan, Heather Lau
Background and ObjectiveGM2 gangliosidosis (Tay-Sachs and Sandhoff diseases) are rare, inherited neurodegenerative disorders with no available symptomatic or disease modifying treatments. This clinical trial aimed to investigate the safety and effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b9aa38e371f8ad3933e4a8b040e2fd5
https://doi.org/10.1101/2021.09.24.21264020
https://doi.org/10.1101/2021.09.24.21264020
Autor:
Ramón Reñé, Maria P. Armengol, Dolores Vilas, Ana Gámez-Valero, Jaume Campdelacreu, Ramiro Álvarez, Katrin Beyer, Jordi Gascón-Bayarri, Lourdes Ispierto, Francesc E. Borràs
Publikováno v:
Biomedicines, Vol 9, Iss 1272, p 1272 (2021)
Biomedicines
Volume 9
Issue 9
Dipòsit Digital de la UB
Universidad de Barcelona
Biomedicines
Volume 9
Issue 9
Dipòsit Digital de la UB
Universidad de Barcelona
Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia, after Alzheimer’s disease (AD), and presents pathological and clinical overlap with both AD and Parkinson’s disease (PD). Consequently, only one in three D